Uls Sao Jose - Hosp. Santa Marta

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Active, not recruiting	Phase 3	2026-10-06		NCT04273945
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension	cardiovascular disorder, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder	Active, not recruiting	Phase 3	2026-09-25		NCT04175600

Clinical trials